Investor FAQs

Investor FAQs

Where is the Company’s corporate headquarters?
Our corporate headquarters is located at Baarerstrasse 14, 6300 Zug, Switzerland, and our U.S. headquarters is located at 610 Main Street, Cambridge, MA 02139.
When was the Company founded?
We were founded in 2013.
Where is the Company incorporated?
We were incorporated as a Swiss stock corporation (Aktiengesellschaft) on October 31, 2013 under the name Inception Genomics AG and changed our name to CRISPR Therapeutics AG on April 28, 2014. Our principal executive offices are located at Baarerstrasse 14, 6300 Zug, Switzerland.
When did the Company go public?
We completed our initial public offering in October 2016.
What is the Company’s fiscal year?
Our fiscal year ends December 31st.
How is the Company’s stock traded?
Our common stock is listed on the NASDAQ Market under the symbol “CRSP”.
Who is the Company’s transfer agent?
The transfer agent and registrar of our common stock is American Stock Transfer and Trust Company LLC.

6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449
Whom do I contact with questions about my stock?
For questions about your stock please contact our transfer agent, American Stock Transfer and Trust Company LLC.

6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449
How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?
To change the address on your shareholder account you must send both your old and new addresses to our transfer agent, American Stock Transfer and Trust Company LLC.

6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449

To replace a lost stock certificate, contact our transfer agent, American Stock Transfer and Trust Company LLC. The transfer agent can look up your records and make any necessary adjustments.
Does the Company have a direct stock purchase plan?
We do not have a direct stock purchase plan.
Who is the Company’s auditor?
Our auditor is Ernst & Young, LLP.
Who is the Company’s legal counsel?
Our legal counsel is Goodwin Proctor, LLP located in Boston, Massachusetts.
Where can I find out more about the Company?
To find out more about us visit our webpage at www.crisprtx.com.
Where can I get the latest corporate news releases and financial reports?
Our press release archive can be viewed under the “Press Releases” section and our financial reports are available under the “Financial Information” section, both under the “Investors” link on our website www.crisprtx.com.
How can I view documents the Company has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
Our SEC Filings can be found on www.sec.gov and are also available under the “Financial Information” section under the “Investors” link on our website www.crisprtx.com.
Who makes up the Company’s Executive Management team and Board of Directors?
For a list of our Executive Management team and Board of Directors please visit the “About Us” tab of our website.
Whom should I contact regarding investor inquiries?
For investor inquiries please contact:
Susan Kim
CRISPR Therapeutics
E-mail: susan.kim@crisprtx.com
Where are the PFIC Annual Information Statements posted?
Please view our PFIC Annual Information Statements under the “SEC Filings” section of our website.